EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dual-State Tumor-Activated RNA Delivery for Tumor-Selective and Precision Therapy

Yuanshuai Song, Tian Jiang, Xin Shen, Wanphiwat Chintrakulchai, Koki Yanagida, Keisuke Iida, Motoaki Kobayashi, Kyohei Muguruma iD, Yuto Honda iD, Haochen Guo iD, Hiroyasu Takemoto iD, Yutaka Miura iD und 1 weitere

ACS Applied Materials & Interfaces · 04.11.2026 · 18 (43) · 59056-59073

DOI: 10.1021/acsami.6c16995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 21.10.2026. Verfasst von Yuanshuai Song und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science and Technology, School of Life Science and Technology, Institute of Science Tokyo, 4259 Nagatsuta-cho, Midori-ku, Yokohama…. Hauptthemen laut MEDLINE: RNA, Messenger, Neoplasms. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA therapeutics hold transformative potential for precision oncology; however, their systemic application remains constrained by a fundamental tradeoff between prolonged circulation stability and efficient intracellular activation. Conventional polyethylene glycol (PEG)-based carriers provide antifouling protection but lack tumor responsiveness, resulting in limited tumor accumulation and suboptimal gene expression. In this study, we developed a nanosystem, the dual-state tumor-activated RNA platform (D-STAR), which enables a dynamic transition from a stealth circulatory state to an activated transfection state through stepwise environmental alternation by recognizing a narrow pH window. At physiological pH, D-STAR maintains a negative surface potential to minimize nonspecific interactions and extend its blood circulation. Within the tumor microenvironment and endo-/lysosomal compartments, progressive protonation induces charge reversal and strengthens cationic activation, thereby enhancing tumor retention, cellular uptake, and cytoplasmic mRNA release. The systemic administration of D-STAR enabled tumor-selective mRNA expression with limited off-target organ distribution and markedly enhanced intratumoral reporter activity compared with PEG-based controls. The therapeutic delivery of human neutrophil elastase mRNA suppressed tumor growth and prolonged survival in a CT26 syngeneic model without systemic toxicity. Collectively, D-STAR establishes a dual-state adaptive RNA delivery framework that decouples systemic stability from activation potency, thereby offering a generalizable strategy for context-responsive precision RNA therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, MessengerNeoplasmsAnimalsHumansMiceCell Line, TumorPolyethylene GlycolsFemaleHydrogen-Ion ConcentrationPrecision MedicineTumor MicroenvironmentMice, Inbred BALB CNanoparticles

Stichwörter der Autor:innen

adaptive surface regulationmRNA deliverypH-responsive nanocarrierpolyzwitterionprecision oncology

Substanzen

Polyethylene GlycolsRNA, Messenger

Autor:innen und Institutionen

  • Department of Life Science and Technology, School of Life Science and Technology, Institute of Science Tokyo, 4259 Nagatsuta-cho, Midori-ku, Yokohama, Kanagawa226-8501, Japan.
  • Laboratory for Chemistry and Life Science, Institute of Integrated Research, Institute of Science Tokyo, 4259 Nagatsuta-cho, Midori-ku, Yokohama, Kanagawa226-8501, Japan.
  • Innovation Center of Nano Medicine (iCONM), Kawasaki Institute of Industrial Promotion, 3-25-14 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa210-0821, Japan.
  • Medical Chemistry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 1-5 Shimogamohangi-cho, Sakyo-ku, Kyoto606-0823, Japan.

ORCID-Profile: Kyohei Muguruma, Yuto Honda, Haochen Guo, Hiroyasu Takemoto, Yutaka Miura

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency

Zitieren

APA

Song, Y., Jiang, T., Shen, X., Chintrakulchai, W., Yanagida, K., Iida, K., Kobayashi, M., Muguruma, K., Honda, Y., Guo, H., Takemoto, H., Miura, Y., & Nishiyama, N. (2026). Dual-State Tumor-Activated RNA Delivery for Tumor-Selective and Precision Therapy. ACS Applied Materials & Interfaces, 18(43), 59056-59073. https://doi.org/10.1021/acsami.6c16995

Vancouver

Song Y, Jiang T, Shen X, Chintrakulchai W, Yanagida K, Iida K, et al. Dual-State Tumor-Activated RNA Delivery for Tumor-Selective and Precision Therapy. ACS Applied Materials & Interfaces. 2026;18(43):59056-59073. doi:10.1021/acsami.6c16995

BibTeX
@article{Song2026,
  author = {Song, Yuanshuai and Jiang, Tian and Shen, Xin and Chintrakulchai, Wanphiwat and Yanagida, Koki and Iida, Keisuke and Kobayashi, Motoaki and Muguruma, Kyohei and Honda, Yuto and Guo, Haochen and Takemoto, Hiroyasu and Miura, Yutaka and Nishiyama, Nobuhiro},
  title = {Dual-State Tumor-Activated RNA Delivery for Tumor-Selective and Precision Therapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  volume = {18},
  number = {43},
  pages = {59056--59073},
  doi = {10.1021/acsami.6c16995}
}
Kostenlos starten →